NBD AI Bulletin -- Guangzhou Kingmed Diagnostics Group Co., Ltd (SH 603882, close price: 123.33 yuan) on March 8 announced that the Company recently received a notice from the China Securities Regulatory Commission, saying that the latter approved the Company's non-public offering of no more than 3.12 million new shares.

The 2019 annual report shows that Guangzhou Kingmed Diagnostics Group mainly engages in third-party medical diagnosis, accounting for 94.22% of its revenue.

Guangzhou Kingmed Diagnostics Group's general manager and chairman is Liang Yaoming, male, 57 years old, Chinese national, no overseas permanent residency, MBA.

(By Gao Han)

Disclaimer: The content and data of this article are for reference only and do not constitute investment advice. Please verify before use. Any action you take upon the information on this website is at your own risk.